Dermatologic Adverse Events Associated with T-Cell Engager Therapy
{{output}}
T-cell engager therapies, including bispecific T-cell engagers and the immune-mobilizing monoclonal T-cell receptor against cancer tebentafusp, are an emerging class of anticancer immunotherapy, with rapid expansion of the class since initial approval of blina... ...
